0,975  0,001  Androgen antagonist
0,968  0,002  Embryotoxic
0,968  0,002  Teratogen
0,904  0,005  Antiinflammatory
0,904  0,005  Apoptosis agonist
0,886  0,003  Cytostatic
0,795  0,004  Cholesterol antagonist
0,790  0,002  UGT1A4 substrate
0,755  0,008  Antihypercholesterolemic
0,741  0,004  CYP2C19 inhibitor
0,720  0,005  NOS3 expression inhibitor
0,668  0,012  Respiratory analeptic
0,668  0,025  Antineoplastic (breast cancer)
0,632  0,011  Atherosclerosis treatment
0,641  0,027  Transcription factor NF kappa B inhibitor
0,608  0,005  CYP3A4 inhibitor
0,609  0,007  Antifungal
0,604  0,004  Contraceptive
0,606  0,023  Antileukemic
0,576  0,015  Antineoplastic (cervical cancer)
0,583  0,022  Antibacterial
0,579  0,019  Immunostimulant
0,550  0,009  UDP-glucuronosyltransferase substrate
0,537  0,005  Prostatic (benign) hyperplasia treatment
0,548  0,017  Antineoplastic (pancreatic cancer)
0,540  0,013  Nitric oxide antagonist
0,560  0,036  Antineoplastic (lung cancer)
0,541  0,016  Proliferative diseases treatment
0,547  0,035  Alzheimer's disease treatment
0,539  0,035  CYP3A4 substrate
0,513  0,009  UGT2B4 substrate
0,508  0,021  Analeptic
0,492  0,009  Interleukin 2 agonist
0,483  0,006  Abortion inducer
0,480  0,006  Prostate disorders treatment
0,480  0,010  Interleukin agonist
0,489  0,021  Antioxidant
0,496  0,034  Immunosuppressant
0,488  0,026  Cytotoxic
0,469  0,013  Antineoplastic (liver cancer)
0,490  0,036  Antipruritic, allergic
0,454  0,007  UGT2B7 substrate
0,460  0,020  ICAM1 expression inhibitor
0,441  0,009  Interferon gamma antagonist
0,466  0,034  Bone diseases treatment
0,449  0,023  Chemopreventive
0,450  0,028  Antiosteoporotic
0,429  0,010  Sodium/bile acid cotransporter inhibitor
0,439  0,033  Spasmolytic
0,443  0,043  Prostate cancer treatment
0,410  0,015  Anesthetic general
0,397  0,009  Lipocortins synthesis antagonist
0,418  0,033  Apoptosis antagonist
0,418  0,033  CTGF expression inhibitor
0,422  0,038  CYP2C19 substrate
0,408  0,041  Hepatic disorders treatment
0,428  0,068  TNF expression inhibitor
0,400  0,040  AR expression inhibitor
0,345  0,007  UGT2B9 substrate
0,344  0,008  Psychosexual dysfunction treatment
0,363  0,029  Psychostimulant
0,378  0,049  Antineoplastic (ovarian cancer)
0,383  0,057  Antineoplastic (colorectal cancer)
0,327  0,009  Cholesterol synthesis inhibitor
0,355  0,038  Cardiovascular analeptic
0,333  0,018  Antiacne
0,335  0,021  Hepatoprotectant
0,353  0,042  Sensitization
0,352  0,044  Hypoxia-inducible factor 1 alpha inhibitor
0,347  0,045  Chemoprotective
0,360  0,058  Antineoplastic (colon cancer)
0,343  0,045  NOS2 expression inhibitor
0,312  0,015  Neurotrophic factor enhancer
0,322  0,027  Platelet adhesion inhibitor
0,310  0,017  Cholinergic
0,300  0,020  Hair growth stimulant
0,395  0,114  Caspase 9 stimulant
0,308  0,038  Antineoplastic (sarcoma)
0,321  0,053  Antineoplastic (endocrine cancer)
0,266  0,003  Glycine receptor agonist
0,345  0,083  CYP2C9 substrate
0,284  0,025  Antipruritic, non-allergic
0,277  0,020  Antiviral (Influenza A)
0,273  0,017  Acetylcholine antagonist
0,273  0,017  Cholinergic antagonist
0,273  0,022  UGT2B15 substrate
0,252  0,002  RNA-directed RNA polymerase stimulant
0,254  0,008  Contraceptive male
0,261  0,018  Acetylcholinesterase inhibitor
0,254  0,012  UGT2B10 substrate
0,249  0,012  Neurotrophic factor
0,243  0,009  Contraceptive female
0,248  0,017  DNA polymerase I inhibitor
0,238  0,008  Hedgehog signaling inhibitor
0,269  0,040  UGT1A1 substrate
0,244  0,019  Antihyperlipoproteinemic
0,219  0,003  Glycine receptor antagonist
0,230  0,015  Farnesoid X receptor antagonist
0,220  0,004  Androgen agonist
0,225  0,014  Arachidonic acid antagonist
0,254  0,045  Antiviral (Influenza)
0,292  0,086  Antineoplastic (brain cancer)
0,279  0,082  Cardioprotectant
0,207  0,019  Endometrios treatment
0,192  0,005  Anabolic
0,214  0,034  Toxic, respiratory center
0,203  0,023  Autism spectrum disorders treatment
0,198  0,021  Antineoplastic antibiotic
0,200  0,024  Acetylcholine muscarinic antagonist
0,181  0,009  Postmenopausal disorders treatment
0,207  0,038  Anesthetic
0,177  0,009  SULT1E1 substrate
0,253  0,090  Radioprotector
0,240  0,079  Antineoplastic (glioma)
0,182  0,023  Growth stimulant
0,247  0,095  Antineoplastic (melanoma)
0,162  0,011  UGT2B11 substrate
0,237  0,091  UGT1A9 substrate
0,223  0,079  Antihypotensive
0,237  0,098  Lipoprotein disorders treatment
0,151  0,013  Aromatase inhibitor
0,162  0,025  UGT2B1 substrate
0,166  0,030  Microtubule formation inhibitor
0,216  0,083  Cardiodepressant
0,140  0,008  Na+ K+ transporting ATPase inhibitor
0,179  0,050  NOS3 expression enhancer
0,151  0,028  Sulfotransferase substrate
0,143  0,021  Antibiotic
0,188  0,067  Diabetic nephropathy treatment
0,203  0,083  Antialcoholic
0,132  0,013  Estrogen agonist
0,207  0,088  UGT1A6 substrate
0,209  0,090  Angiogenesis stimulant
0,191  0,072  VEGF expression inhibitor
0,150  0,033  Alcohol dehydrogenase substrate
0,141  0,028  Estrogen antagonist
0,229  0,119  CYP2D6 substrate
0,116  0,009  5-Alpha-reductase inhibitor
0,110  0,004  Lipocortins synthesis agonist
0,138  0,033  Antiinfertility, female
0,110  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,120  0,016  Premenstrual syndrome treatment
0,109  0,008  Estrogen receptor alpha agonist
0,116  0,015  Cushing's syndrome treatment
0,109  0,010  Estrogen receptor beta agonist
0,147  0,049  Antihemorrhagic
0,095  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,192  0,100  Antineoplastic (lymphoma)
0,160  0,069  Melanin inhibitor
0,092  0,005  Glucocorticoid antagonist
0,119  0,033  Estrogen receptor beta antagonist
0,128  0,043  Butyrylcholinesterase inhibitor
0,187  0,104  Hypolipemic
0,094  0,012  SULT2A1 substrate
0,086  0,005  5-Alpha-reductase 2 inhibitor
0,097  0,019  Anticholelithogenic
0,088  0,011  Andropause treatment
0,107  0,036  Bile acid receptor antagonist
0,139  0,069  Amylase inhibitor
0,078  0,012  Mineralocorticoid receptor antagonist
0,168  0,104  Antineoplastic (glioblastoma multiforme)
0,195  0,136  Antineurogenic pain
0,103  0,046  ABCA1 expression enhancer
0,057  0,003  Hedgehog signaling activator
0,068  0,015  Aldosterone antagonist
0,222  0,170  Inflammatory Bowel disease treatment
0,059  0,010  Hypogonadism treatment
0,062  0,014  Progesterone antagonist
0,092  0,048  Transcription factor NF kappa B stimulant
0,146  0,102  Carcinogenic
0,047  0,005  Glucocorticoid agonist
0,045  0,003  Corticosteroid-like
0,149  0,108  Phospholipase C inhibitor
0,093  0,055  Actinic keratosis treatment
0,087  0,050  Antiprotozoal activity enhancer
0,131  0,098  Pregnane X receptor agonist
0,182  0,150  DNA synthesis inhibitor
0,040  0,008  5-Alpha-reductase 1 inhibitor
0,096  0,065  Anticataract
0,046  0,015  Cholesterol absorption inhibitor
0,127  0,096  Skeletal muscle relaxant
0,036  0,006  Progesterone agonist
0,156  0,128  Growth factor agonist
0,051  0,027  Microtubule stabilization
0,152  0,130  Antiparasitic
0,059  0,036  Postcoital contraceptive
0,136  0,113  Interleukin 6 antagonist
0,031  0,010  Estrone sulfatase inhibitor
0,076  0,056  Estrogen receptor alpha antagonist
0,125  0,107  UGT1A3 substrate
0,035  0,022  HMG CoA reductase inhibitor
0,156  0,144  Antineoplastic enhancer
0,059  0,048  Heme oxygenase stimulant
0,034  0,024  Tubulin agonist
0,144  0,135  Antihypertriglyceridemic
0,011  0,002  Transcortin receptor antagonist
0,051  0,042  Acetylcholine M2 receptor agonist
0,124  0,116  Adenylate cyclase stimulant
0,022  0,015  Vitamin D receptor antagonist
0,013  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,043  0,037  Parathyroid hormone antagonist
0,027  0,020  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,040  0,034  Opioid kappa receptor agonist
0,069  0,065  SULT1A2 substrate
0,047  0,044  Protein 50S ribosomal subunit inhibitor
0,078  0,077  Antineoplastic, alkylator

